Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
As a dual agonist for GIP and GLP-1 receptors, tirzepatide may provide superior weight reduction compared to selective GLP-1 agonists by targeting additional tissues and integrating signals from both receptor pathways in the brain.8,9 The efficacy of tirzepatide was evaluated in a phase 3 randomized withdrawal clinical trial (NCT04660643) with a 36-week, open-label tirzepatide lead-in period, followed by a 52-week, double-blind, placebo-controlled period, conducted at 70 sites in Argentina, Brazil, Taiwan, and the United States
They indicate either incomplete dissolution, aggregated peptide, or contamination
Some users compare bacteriostatic water with sterile water alternatives
contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
US$ 21.38
US$ 26.87
US$ 29.41
US$ 21.62
US$ 23.01
US$ 26.78
